Sofinnova Investments as of Sept. 30, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 68 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera Comm (NTRA) | 16.9 | $224M | 3.1M | 72.24 | |
| Ascendis Pharma A/S Adr (ASND) | 13.0 | $171M | 1.1M | 154.32 | |
| Karuna Therapeutics Comm | 11.4 | $151M | 2.0M | 77.32 | |
| Y-mAbs Therapeutics Comm | 6.4 | $84M | 2.2M | 38.39 | |
| Inozyme Pharma Comm (INZY) | 4.0 | $53M | 2.0M | 26.29 | |
| Checkmate Pharmaceuticals Comm | 3.1 | $42M | 3.6M | 11.51 | |
| Akouos Adr | 2.6 | $35M | 1.5M | 22.87 | |
| United Therapeutics Corp Comm (UTHR) | 2.5 | $32M | 321k | 101.00 | |
| Abbvie Comm (ABBV) | 2.3 | $30M | 341k | 87.59 | |
| Nucana Biomed Adr | 2.2 | $29M | 5.6M | 5.17 | |
| Amgen Comm (AMGN) | 2.1 | $28M | 112k | 254.16 | |
| Galera Therapeutics Comm (GRTX) | 2.1 | $28M | 3.1M | 9.04 | |
| Nextcure Comm (NXTC) | 1.8 | $24M | 2.7M | 8.80 | |
| Lilly Eli & Co Comm (LLY) | 1.6 | $21M | 142k | 148.02 | |
| Insmed Comm (INSM) | 1.5 | $20M | 615k | 32.14 | |
| Biomarin Pharmaceutical Comm (BMRN) | 1.5 | $20M | 259k | 76.08 | |
| PTC Therapeutics Comm (PTCT) | 1.4 | $19M | 405k | 46.75 | |
| Jazz Pharmaceuticals Comm (JAZZ) | 1.4 | $19M | 130k | 142.60 | |
| Merck & Co Comm (MRK) | 1.2 | $16M | 191k | 82.95 | |
| Merus Comm (MRUS) | 1.2 | $16M | 1.3M | 12.00 | |
| Amgen Comm Call Option | 1.1 | $15M | 60k | 254.12 | |
| Intra-Cellular Therapies Comm (ITCI) | 1.0 | $13M | 504k | 25.66 | |
| Nucana Biomed Ordinary Shares | 0.9 | $12M | 2.4M | 5.17 | |
| ObsEva SA Comm | 0.9 | $12M | 4.7M | 2.48 | |
| Athira Pharma Comm (ATHA) | 0.7 | $9.4M | 509k | 18.46 | |
| Marinus Pharmaceuticals Comm Call Option | 0.7 | $9.0M | 175k | 51.40 | |
| Otonomy Comm | 0.6 | $8.6M | 2.1M | 4.05 | |
| GW Pharmaceuticals Adr | 0.6 | $8.1M | 83k | 97.36 | |
| Coherus BioSciences Comm (CHRS) | 0.6 | $8.0M | 435k | 18.34 | |
| Cytokinetics Comm (CYTK) | 0.6 | $7.6M | 349k | 21.65 | |
| Zymeworks Comm | 0.5 | $7.1M | 152k | 46.57 | |
| Cytokinetics Comm Put Option | 0.5 | $7.0M | 325k | 21.65 | |
| Protagonist Therapeutics Comm (PTGX) | 0.5 | $7.0M | 358k | 19.55 | |
| Kura Oncology Comm (KURA) | 0.5 | $6.9M | 225k | 30.64 | |
| Supernus Pharmaceuticals Comm (SUPN) | 0.5 | $6.9M | 330k | 20.84 | |
| Acceleron Pharma Comm | 0.5 | $6.7M | 60k | 112.52 | |
| TG Therapeutics Comm (TGTX) | 0.5 | $6.7M | 250k | 26.76 | |
| Reata Pharmaceuticals Comm | 0.5 | $6.7M | 69k | 97.43 | |
| MyoKardia Comm | 0.5 | $6.7M | 49k | 136.35 | |
| Arena Pharmaceuticals Comm | 0.5 | $6.6M | 88k | 74.78 | |
| Ovid Therapeutics Comm (OVID) | 0.5 | $6.3M | 1.1M | 5.74 | |
| Mirum Pharmaceuticals Comm (MIRM) | 0.5 | $6.2M | 321k | 19.27 | |
| Reata Pharmaceuticals Comm Put Option | 0.4 | $5.8M | 60k | 97.41 | |
| Novocure Comm Call Option | 0.4 | $5.6M | 50k | 111.33 | |
| Amarin Corp Adr | 0.4 | $4.9M | 1.2M | 4.21 | |
| Aclaris Therapeutics Comm (ACRS) | 0.4 | $4.9M | 1.9M | 2.57 | |
| Puma Biotechnology Comm (PBYI) | 0.4 | $4.8M | 476k | 10.09 | |
| Chiasma Comm | 0.3 | $4.5M | 1.0M | 4.30 | |
| ChemoCentryx Comm | 0.3 | $4.5M | 81k | 54.79 | |
| Kiniksa Pharmaceuticals Comm Cl A | 0.3 | $4.2M | 277k | 15.32 | |
| Applied Genetic Technologies Corp Comm | 0.3 | $4.0M | 825k | 4.86 | |
| Moderna Comm Call Option | 0.3 | $3.5M | 50k | 70.73 | |
| TCR2 Therapeutics Comm | 0.3 | $3.5M | 173k | 20.32 | |
| Immatics NV Comm (IMTX) | 0.3 | $3.5M | 326k | 10.61 | |
| Liquidia Technologies Comm (LQDA) | 0.3 | $3.3M | 679k | 4.92 | |
| BioCryst Pharmaceuticals Comm (BCRX) | 0.2 | $2.7M | 793k | 3.44 | |
| Homology Medicines Comm | 0.2 | $2.5M | 238k | 10.70 | |
| Kadmon Holdings Comm | 0.2 | $2.5M | 630k | 3.92 | |
| Compugen Comm (CGEN) | 0.2 | $2.4M | 147k | 16.25 | |
| Entasis Therapeutics Holdings Comm | 0.2 | $2.1M | 1.0M | 2.04 | |
| ACADIA Pharmaceuticals Comm (ACAD) | 0.2 | $2.0M | 49k | 41.26 | |
| Calithera Biosciences Comm | 0.1 | $1.7M | 493k | 3.45 | |
| Fate Therapeutics Comm (FATE) | 0.1 | $1.7M | 41k | 39.94 | |
| Regenxbio Comm (RGNX) | 0.1 | $1.6M | 60k | 27.53 | |
| Synlogic Comm | 0.1 | $1.2M | 575k | 2.02 | |
| Savara Comm (SVRA) | 0.0 | $409k | 376k | 1.09 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.0 | $332k | 143k | 2.33 | |
| Kadmon Holdings Warrant | 0.0 | $137k | 240k | 0.57 |